Health Care & Hospital Law,
Civil Litigation
Jul. 22, 2021
Plaintiffs urge all states to agree to $26B opioid deal, California case nears end
“If we don’t get the critical mass of the states, we’re done; this deal fails,” said Joseph F. Rice of Motley Rice LLP.
Joseph F. Rice of Motley Rice LLP said if most attorneys general don't agree to the $26B global opioid deal it will fail. (Courtesy of Motley Rice LLP)
Drug companies accused of fueling the state's opioid crisis in a $50 billion bench trial in Orange County called their last witness Wednesday as a plaintiffs' committee urged attorneys general nationwide to sign onto a $26 billion global settlement.
At a virtual press conference Wednesday, Joseph F. Rice of Motley Rice LLP, who as a member of the Plaintiffs' Executive Committee is negotiating the settlement terms on behalf of 3,000 ...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In
Enewsletter Sign-up
Related Content
Health Care & Hospital Law, Civil Litigation
6 states not yet in national opioid settlement
Aug. 26, 2021
By Blaise Scemama
By Blaise Scemama
Health Care & Hospital Law, Civil Litigation
Challenge to pharmacy’s opioid control is dismissed
Sep. 1, 2021
By Winston Cho
By Winston Cho
Health Care & Hospital Law, Civil Litigation
Some plaintiffs are asking if $26B opioid settlement is enough
Sep. 2, 2021
By Blaise Scemama
By Blaise Scemama
Government, Civil Litigation, Bankruptcy
California to appeal Purdue Pharma settlement
Sep. 27, 2021
By Blaise Scemama
By Blaise Scemama
Health Care & Hospital Law, Civil Litigation
State’s opioid trial goes on, seeks twice the amount of global settlement
Jul. 21, 2021
By Blaise Scemama
By Blaise Scemama
Health Care & Hospital Law, Civil Litigation
No link between J&J opioids and sales in California, expert testifies
Jul. 13, 2021
By Blaise Scemama
By Blaise Scemama
Health Care & Hospital Law, Civil Litigation
California joins opponents of $4.5B Purdue Pharma settlement
Jul. 9, 2021
By Craig Anderson
By Craig Anderson
Health Care & Hospital Law, Civil Litigation
Former J&J medical consultant testifies in OC opioid trial
Jul. 7, 2021
By Blaise Scemama
By Blaise Scemama
Health Care & Hospital Law, Civil Litigation
Most opioid addicts had history of drug abuse, doctor testifies
Jul. 1, 2021
By Blaise Scemama
By Blaise Scemama
